Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Korean Mountain Ginseng (Panax ginseng) is a wild-grown root uniquely enriched in ginsenosides Rg3, Rg5, and Rk1 that modulate MAPK/NF-κB, PI3K/Akt/mTOR, and FoxO3 signaling pathways, conferring significantly superior anticancer, anti-angiogenic, and anti-atrophic effects compared to farm-cultivated ginseng. In a landmark 2020 study (PMID 32774407), mountain ginseng demonstrated markedly greater cytotoxicity against MCF-7 human breast cancer cells than cultivated ginseng, while a 2021 study (PMID 33161026) confirmed it inhibits skeletal muscle atrophy by downregulating MuRF-1 and atrogin-1 via the FoxO3 pathway in L6 myotubes.
Reported Benefits (Provisional)
Origin & History
Korean Mountain Ginseng (Panax ginseng) is a revered adaptogenic herb native to the mountainous regions of Korea, China, and parts of Siberia. It thrives in cool, shaded environments with well-drained, nutrient-rich soils. This botanical is prized for its potent health-enhancing properties.
Research Narrative (Provisional)
Kim J et al. (2020) in Evidence-Based Complementary and Alternative Medicine (PMID 32774407) demonstrated that mountain ginseng exhibited significantly greater anticancer effects against MCF-7 human breast cancer cells compared to farm-cultivated ginseng, attributable to higher concentrations of ginsenosides Rg3, Rg5, and Rk1. Kim JS et al. (2021) in Molecular Medicine Reports (PMID 34225442) confirmed mountain ginseng's superior anti-angiogenic activity in both HUVEC tube formation assays (in vitro) and in vivo models compared to cultivated ginseng. Seok YM et al. (2021) in the Journal of Ethnopharmacology (PMID 33161026) showed that mountain ginseng inhibits skeletal muscle atrophy by decreasing MuRF-1 and atrogin-1 expression through the FoxO3 transcription factor pathway in L6 myotubes. Additionally, Dou JY et al. (2025) in the Journal of Ethnopharmacology (PMID 40318772) reported that ginseng ameliorated pulmonary fibrosis and inflammation by targeting the TLR4-P2X7r/NLRP3 signaling pathway, underscoring its broad anti-inflammatory potential.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Ginsenosides: Key bioactive compounds responsible for adaptogenic effects, energy modulation, and immune support. - Polysaccharides: Contribute to adaptogenic and neuroprotective functions. - Panaxosides: Support cognitive function and stress response. - Flavonoids: Promote circulatory and metabolic health. - Sterols: Aid in hormonal balance and longevity.
Reported Mechanism (Provisional)
The primary bioactive ginsenosides Rb1, Rg1, Rg3, Rg5, and Rk1 activate macrophages through MAPK/NF-κB signaling cascades—specifically phosphorylating ERK1/2, JNK, and p38 MAPK—which upregulates pro-inflammatory cytokines TNF-α and IL-6 for immune priming, while ginsenoside Rg1 selectively engages the PI3K/Akt/mTOR axis to promote cell survival, protein synthesis, and neuroplasticity. Mountain ginseng's anti-atrophic mechanism involves the suppression of FoxO3 nuclear translocation, thereby downregulating the E3 ubiquitin ligases MuRF-1 (muscle RING finger protein-1) and atrogin-1/MAFbx, which are primary drivers of proteasome-mediated skeletal muscle degradation (PMID 33161026). Its anti-angiogenic activity, superior to cultivated ginseng, involves inhibition of VEGF-mediated endothelial cell proliferation and tube formation (PMID 34225442). Furthermore, ginseng targets the TLR4-P2X7r/NLRP3 inflammasome axis to suppress IL-1β maturation and pyroptosis-driven fibrotic remodeling (PMID 40318772).
Clinical Narrative (Provisional)
Current research on Korean Mountain Ginseng is primarily preclinical, with no specific human clinical trials identified in recent literature. Pharmacokinetic studies show 25-OH-PPD has 64.8±14.3% absolute bioavailability, the highest among ginsenosides tested. Four-year-old Geumsan Korean samples demonstrated the highest ginsenoside content compared to Chinese and Japanese varieties. Rigorous randomized controlled trials are needed to establish clinical efficacy in humans.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.